[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.205.0.26. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
May 1993

Dissociation Between Pituitary and Adrenal Suppression to Dexamethasone in Depression

Arch Gen Psychiatry. 1993;50(5):395-403. doi:10.1001/archpsyc.1993.01820170073010
Abstract

Objective:  To determine if corticotroph nonsuppression, as reflected by β-endorphin nonsuppression, occurs before cortisol nonsuppression (defined as a cortisol level of >140 nmol/L) when examining multiple time points in a day.

Setting:  The General Medical Clinical Research Center and Inpatient Depression Research Unit, Ann Arbor, Mich.

Design:  Multiple blood samples were obtained through an intravenous catheter around the time points of 8 AM, noon, and 4 PM and assayed for β-endorphin and cortisol.

Patients:  Patients meeting Research Diagnostic Criteria for the diagnosis of major depressive disorder, primary and simple. A total of 73 subjects, both inpatients and outpatients, were studied.

Intervention:  Samples were obtained both at baseline and 1 day after administration of 1 mg of dexamethasone at 11:30 PM.

Measurements and Results:  Overall 39 patients (53%) demonstrated β-endorphin nonsuppression after administration of dexamethasone at any of the three time points, while only eight patients (11%) demonstrated cortisol nonsuppression at any of these time points. Cortisol nonsuppression, but not β-endorphin nonsuppression, was associated with lower concentrations of dexamethasone in plasma. Baseline cortisol and menopausal status were significantly associated with β-endorphin nonsuppression in women.

×